On Monday, April 21, Roslyn resident Roberta Leventhal will run to conquer cancer as a member of the Dana-Farber Marathon Challenge team in the 118th Boston Marathon.
Leventhal, along with more than 700 Dana-Farber Marathon Challenge teammates from across the United States and around the world, will run the historic marathon’s route from Hopkinton to Boston with a goal to raise $5.3 million for cancer research at Dana-Farber Cancer Institute.
This year marks the 25th annual running of the Dana-Farber Marathon Challenge. One hundred percent of the money raised by the Dana-Farber Marathon Challenge team funds Dana-Farber’s Claudia Adams Barr Program in Innovative Basic Cancer Research. The Barr Program supports cornerstone science research in its earliest stages, providing researchers with critical resources to test their leading-edge ideas. Findings from Barr Program research can provide the results necessary to seek additional federal funding as well as novel clinical insights.
Dana-Farber Marathon Challenge runners include cancer survivors and patients, and family and friends of those who have been affected by cancer. Runners of all abilities participate with the goal to help put an end to cancer.
This year’s field is expected to see 36,000 runners in competition, the most since 1996.
